GeneScience Pharmaceuticals
GeneScience Pharmaceuticals Co., Ltd. is a biopharmaceutical company based in Changchun, China, specializing in the development and production of recombinant human growth hormone products. Established in 1996, the company’s product line includes Jintropin AQ, Jintropin for Injection for burn treatment, Genfulin for deep II-degree burns and wound healing, and Jintrotide, a synthetic octapeptide that regulates the secretion of growth hormone. These products cater to various medical fields, including burns, assisted reproduction, anti-aging, and oncology. GeneScience Pharmaceuticals operates a manufacturing facility that spans over 20,000 square meters, with a dedicated production area of 11,000 square meters. The company distributes its products through a network of distributors in multiple countries, including China, Colombia, Hong Kong, Russia, Ukraine, Uzbekistan, and Mexico.
1 past transactions
Rani Therapeutics
Venture Round in 2018
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company that focuses on the development of oral delivery technologies for large drug molecules, such as peptides, proteins, and antibodies. The company has created the RaniPill capsule, a proprietary and patented platform designed to administer biologics orally, offering a convenient alternative to traditional subcutaneous or intravenous injections. This capsule is engineered to deliver precise therapeutic doses upon reaching the small intestine. Rani Therapeutics is advancing various treatments, including TNFa inhibitors for inflammatory disorders, parathyroid hormone for osteoporosis, and human growth hormone for growth deficiencies. Additionally, their portfolio includes therapies for multiple sclerosis, type II diabetes, and various inflammatory diseases. Founded in 2012 and based in San Jose, California, Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety and effectiveness of its technologies, building a robust intellectual property portfolio in the process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.